Reducing regional variations in treatment rates for pancreatic cancer requires an inclusive, standardised approach and cooperation
The successful treatment of pancreatic adenocarcinoma with curative intent depends on a number of factors: the patient must present to a medical service for investigation, the appropriate investigations for diagnosing and staging the disease must be undertaken, and curative surgery and adjuvant therapy must then be considered in an appropriate setting.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.